{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T14:47:28Z","timestamp":1785163648605,"version":"3.55.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.ygyno.2022.06.019","type":"journal-article","created":{"date-parts":[[2022,6,25]],"date-time":"2022-06-25T19:03:44Z","timestamp":1656183824000},"page":"576-581","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Clinical outcome of combined intracavitary \/ interstitial brachytherapy using a hybrid applicator in locally advanced cervical cancer"],"prefix":"10.1016","volume":"166","author":[{"given":"Paul","family":"Rogowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Rottler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Saicic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Niyazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justus","family":"Well","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Nierer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Trillsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Burges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Mahner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Belka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Corradini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ygyno.2022.06.019_bb0005","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.radonc.2012.04.007","article-title":"Impact of 3D image-based PDR brachytherapy on outcome of patients treated for cervix carcinoma in France: results of the French STIC prospective study","volume":"103","author":"Charra-Brunaud","year":"2012","journal-title":"Radiother. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2022.06.019_bb0010","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ygyno.2014.08.027","article-title":"Improved survival of patients with cervical cancer treated with image-guided brachytherapy compared with conventional brachytherapy","volume":"135","author":"Rijkmans","year":"2014","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2022.06.019_bb0015","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.radonc.2004.12.015","article-title":"Recommendations from Gynaecological (GYN) GEC-ESTRO working group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV","volume":"74","author":"Haie-Meder","year":"2005","journal-title":"Radiother. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2022.06.019_bb0020","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.radonc.2005.11.014","article-title":"Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy - 3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiolo","volume":"78","author":"P\u00f6tter","year":"2006","journal-title":"Radiother. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2022.06.019_bb0025","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.radonc.2010.06.004","article-title":"Recommendations from Gynaecological (GYN) GEC-ESTRO working group: considerations and pitfalls in commissioning and applicator reconstruction in 3D image-based treatment planning of cervix cancer brachytherapy","volume":"96","author":"Hellebust","year":"2010","journal-title":"Radiother. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2022.06.019_bb0030","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.radonc.2011.12.024","article-title":"Recommendations from Gynaecological (GYN) GEC-ESTRO working group (IV): basic principles and parameters for MR imaging within the frame of image based adaptive cervix cancer brachytherapy","volume":"103","author":"Dimopoulos","year":"2012","journal-title":"Radiother. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2022.06.019_bb0035","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.radonc.2016.03.011","article-title":"Image guided brachytherapy in locally advanced cervical cancer: improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study","volume":"120","author":"Sturdza","year":"2016","journal-title":"Radiother. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2022.06.019_bb0040","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S1470-2045(20)30753-1","article-title":"MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study","volume":"22","author":"P\u00f6tter","year":"2021","journal-title":"Lancet Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2022.06.019_bb0045","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.radonc.2016.05.014","article-title":"Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer","volume":"120","author":"Tanderup","year":"2016","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.ygyno.2022.06.019_bb0050","first-page":"48","article-title":"The EMBRACE II study: the outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies","volume":"9","author":"P\u00f6tter","year":"2018","journal-title":"Clin. Transl. Radiat. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2022.06.019_bb0055","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.radonc.2016.03.020","article-title":"Image guided adaptive brachytherapy with combined intracavitary and interstitial technique improves the therapeutic ratio in locally advanced cervical cancer: analysis from the retroEMBRACE study","volume":"120","author":"Fokdal","year":"2016","journal-title":"Radiother. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2022.06.019_bb0060","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.radonc.2009.08.014","article-title":"MRI-guided treatment-planning optimisation in intracavitary or combined intracavitary\/interstitial PDR brachytherapy using tandem ovoid applicators in locally advanced cervical cancer","volume":"93","author":"J\u00fcrgenliemk-Schulz","year":"2009","journal-title":"Radiother. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2022.06.019_bb0065","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.ijrobp.2011.04.044","article-title":"Clinical use of the Utrecht applicator for combined intracavitary\/interstitial brachytherapy treatment in locally advanced cervical cancer","volume":"82","author":"Nomden","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"2","key":"10.1016\/j.ygyno.2022.06.019_bb0070","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ijrobp.2006.01.036","article-title":"The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: design, application, treatment planning, and dosimetric results","volume":"65","author":"Kirisits","year":"2006","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.ygyno.2022.06.019_bb0075","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijrobp.2006.04.041","article-title":"The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: clinical feasibility and preliminary results","volume":"66","author":"Dimopoulos","year":"2006","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ygyno.2022.06.019_bb0080","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.radonc.2019.08.004","article-title":"Vienna-II ring applicator for distal parametrial\/pelvic wall disease in cervical cancer brachytherapy: an experience from two institutions: clinical feasibility and outcome","volume":"141","author":"Mahantshetty","year":"2019","journal-title":"Radiother. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2022.06.019_bb0085","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.brachy.2018.05.009","article-title":"Combined intracavitary and interstitial brachytherapy of cervical cancer using the novel hybrid applicator Venezia: clinical feasibility and initial results","volume":"17","author":"Walter","year":"2018","journal-title":"Brachytherapy"},{"issue":"1","key":"10.1016\/j.ygyno.2022.06.019_bb0090","doi-asserted-by":"crossref","first-page":"24","DOI":"10.5114\/jcb.2021.103583","article-title":"Venezia applicator with oblique needles improves clinical target volume coverage in distal parametrial tumor residue compared to parallel needles only","volume":"13","author":"Kissel","year":"2021","journal-title":"J. Contemp. Brachyther."},{"key":"10.1016\/j.ygyno.2022.06.019_bb0095","series-title":"TNM Classification of Malignant Tumors","year":"2017"},{"key":"10.1016\/j.ygyno.2022.06.019_bb0100","author":"U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES"},{"issue":"3","key":"10.1016\/j.ygyno.2022.06.019_bb0105","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.radonc.2016.05.029","article-title":"A volumetric analysis of GTVD and CTVHR as defined by the GEC ESTRO recommendations in FIGO stage IIB and IIIB cervical cancer patients treated with IGABT in a prospective multicentric trial (EMBRACE)","volume":"120","author":"Jastaniyah","year":"2016","journal-title":"Radiother. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2022.06.019_bb0110","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ijrobp.2009.02.036","article-title":"Translating response during therapy into ultimate treatment outcome: a personalized 4-dimensional MRI tumor volumetric regression approach in cervical cancer","volume":"76","author":"Mayr","year":"2010","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.ygyno.2022.06.019_bb0115","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.brachy.2020.08.006","article-title":"Early outcomes after definitive chemoradiation therapy with Vienna\/Venezia hybrid high-dose rate brachytherapy applicators for cervical cancer: a single-institution experience","volume":"20","author":"Keller","year":"2021","journal-title":"Brachytherapy"},{"issue":"3","key":"10.1016\/j.ygyno.2022.06.019_bb0120","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.radonc.2018.09.002","article-title":"Isodose surface volumes in cervix cancer brachytherapy: change of practice from standard (point a) to individualized image guided adaptive (EMBRACE I) brachytherapy","volume":"129","author":"Serban","year":"2018","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.ygyno.2022.06.019_bb0125","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.radonc.2020.10.003","article-title":"Importance of the ICRU bladder point dose on incidence and persistence of urinary frequency and incontinence in locally advanced cervical cancer: an EMBRACE analysis","volume":"158","author":"Spampinato","year":"2021","journal-title":"Radiother. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2022.06.019_bb0130","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.ijrobp.2020.10.006","article-title":"Dose-volume effects and risk factors for late diarrhea in cervix cancer patients after radiochemotherapy with image guided adaptive brachytherapy in the EMBRACE I study","volume":"109","author":"Nina","year":"2021","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.ygyno.2022.06.019_bb0135","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.radonc.2015.12.025","article-title":"Dose-effect relationship and risk factors for vaginal stenosis after definitive radio(chemo)therapy with image-guided brachytherapy for locally advanced cervical cancer in the EMBRACE study","volume":"118","author":"Kirchheiner","year":"2016","journal-title":"Radiother. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2022.06.019_bb0140","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.radonc.2016.06.006","article-title":"Dose\u2013volume effect relationships for late rectal morbidity in patients treated with chemoradiation and MRI-guided adaptive brachytherapy for locally advanced cervical cancer: results from the prospective multicenter EMBRACE study","volume":"120","author":"Mazeron","year":"2016","journal-title":"Radiother. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2022.06.019_bb0145","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.21873\/invivo.12356","article-title":"Pelvic insufficiency fractures in cervical cancer after radiation therapy: a meta-analysis and review","volume":"35","author":"Chung","year":"2021","journal-title":"In Vivo (Brooklyn)"},{"issue":"S201","key":"10.1016\/j.ygyno.2022.06.019_bb0150","article-title":"OC-0392: impact of image-guided brachytherapy on pattern of relapse in the RetroEMBRACE cervical cancer study","volume":"127","author":"Tan","year":"2018","journal-title":"Radiother. Oncol."},{"issue":"18_suppl","key":"10.1016\/j.ygyno.2022.06.019_bb0155","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2021.39.15_suppl.LBA3","article-title":"Adjuvant chemotherapy following chemoradiation as primary treatment for locally advanced cervical cancer compared to chemoradiation alone: the randomized phase III OUTBACK Trial (ANZGOG 0902, RTOG 1174, NRG 0274)","volume":"39","author":"Mileshkin","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2022.06.019_bb0160","first-page":"1","article-title":"Pembrolizumab for persistent, recurrent, or metastatic cervical cancer","author":"Colombo","year":"2021","journal-title":"N. Engl. J. Med."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825822004231?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825822004231?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:01:52Z","timestamp":1758772912000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825822004231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S0090825822004231"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2022.06.019","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical outcome of combined intracavitary \/ interstitial brachytherapy using a hybrid applicator in locally advanced cervical cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2022.06.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}